Open Accessibility Menu

GYN ONC (Gynecologic oncology)

NRG – GY026 at

A Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-OYSK (Herceptin Hylecta™) or pertuzumab, trastuzumab, and hyaluronidase-ZZXF (Phesgo®) in HER2 positive, Stage I-IV endometrial serous carcinoma or carcinosarcoma

Cancer Type: Endometrial serous carcinoma or carcinosarcoma, HER2+

Principal Investigator: Dr. Deborah Brandt

Please contact Clinical Trials Office for more details: 561-263-5791

  • Jupiter Medical Center

    We want to help you! If you have questions about our services and what we can offer you and your loved ones, please reach out.